These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16413845)

  • 41. Intrauterine device use among women with ovarian cancer: a systematic review.
    Zapata LB; Whiteman MK; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):38-40. PubMed ID: 20682141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrauterine device use and the risk of pelvic inflammatory disease.
    Burkman RT
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):861-3. PubMed ID: 7008603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Same-day intrauterine device placement is rarely complicated by pelvic infection.
    Papic M; Wang N; Parisi SM; Baldauf E; Updike G; Schwarz EB
    Womens Health Issues; 2015; 25(1):22-7. PubMed ID: 25445666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device.
    Shelton JD
    Lancet; 2001 Feb; 357(9254):443. PubMed ID: 11273068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of IUD as an etiological factor of acute pelvic inflammatory disease].
    Evron S; Schenker JG
    Harefuah; 1979 Apr; 96(7):344-6. PubMed ID: 385465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconsidering the IUD.
    Petitti DB
    Fam Plann Perspect; 1992; 24(1):33-5. PubMed ID: 1601123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The rise and fall and rise of the IUD.
    Burnhill MS
    Am J Gynecol Health; 1989; 3(3-S):6-10. PubMed ID: 12285000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Summary of the practice guideline 'The intrauterine device' from the Dutch College of General Practitioners].
    Boukes FS; Kertzman MG; Smeenk RC; Goudswaard AN
    Ned Tijdschr Geneeskd; 2009; 153():A578. PubMed ID: 19785853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STD and contraception.
    Chandran R
    Malays J Reprod Health; 1993 Jun; 11(1):1-7. PubMed ID: 12318983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study.
    Lee NC; Rubin GL; Borucki R
    Obstet Gynecol; 1988 Jul; 72(1):1-6. PubMed ID: 3380496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended use of the intrauterine device: a literature review and recommendations for clinical practice.
    Wu JP; Pickle S
    Contraception; 2014 Jun; 89(6):495-503. PubMed ID: 24679478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current concepts on the use of IUDs.
    McCarthy T
    Singapore Med J; 1989 Aug; 30(4):390-2. PubMed ID: 2814545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.